The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Enzyme‐MOF Nanoreactor Activates Nontoxic Paracetamol for Cancer Therapy
Open accessAbstract
Prodrug activation, by exogenously administered enzymes, for cancer therapy is an approach to achieve better selectivity and less systemic toxicity than conventional chemotherapy. However, the short half‐lives of the activating enzymes in the bloodstream has limited its success. Demonstrated here is that a tyrosinase‐MOF nanoreactor activates the prodrug paracetamol in cancer cells in a long‐lasting manner. By generating reactive oxygen species (ROS) and depleting glutathione (GSH), the product of the enzymatic conversion of paracetamol is toxic to drug‐resistant cancer cells. Tyrosinase‐MOF nanoreactors cause significant cell death in the presence of paracetamol for up to three days after being internalized by cells, while free enzymes totally lose activity in a few hours. Thus, enzyme‐MOF nanocomposites are envisioned to be novel persistent platforms for various biomedical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metal–Organic Framework Materials as Chemical Sensors
Kreno, L. E., Leong, K., Farha, O. K., Allendorf, M., Van Duyne, R. P., & Hupp, J. T. (2012) · Chemical Reviews · doi:10.1021/cr200324t · Cited by 7,136
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer Therapy
Wu, M., & Yang, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606134 · Cited by 2,285
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
Della Rocca, J., Liu, D., & Lin, W. (2011) · Accounts of Chemical Research · doi:10.1021/ar200028a · Cited by 2,087
Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules
Liang, K., Ricco, R., Doherty, C. M., Styles, M. J., Bell, S., Kirby, N., Mudie, S., Haylock, D., Hill, A. J., Doonan, C. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8240 · Cited by 1,496
Enzyme–MOF (metal–organic framework) composites
Lian, X., Fang, Y., Joseph, E., Wang, Q., Li, J., Banerjee, S., Lollar, C., Wang, X., & Zhou, H.-C. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00058h · Cited by 1,387
Self-citationTargeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
LOEHRER, P. J., & EINHORN, L. H. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-704 · Cited by 947
Baker, M. A., Cerniglia, G. J., & Zaman, A. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90208-q · Cited by 920
Metal–organic frameworks as potential drug carriers
Huxford, R. C., Della Rocca, J., & Lin, W. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.12.012 · Cited by 840
Shieh, F.-K., Wang, S.-C., Yen, C.-I., Wu, C.-C., Dutta, S., Chou, L.-Y., Morabito, J. V., Hu, P., Hsu, M.-H., Wu, K. C.-W., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/ja513058h · Cited by 774
Stable metal-organic frameworks containing single-molecule traps for enzyme encapsulation
Feng, D., Liu, T.-F., Su, J., Bosch, M., Wei, Z., Wan, W., Yuan, D., Chen, Y.-P., Wang, X., Wang, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms6979 · Cited by 691
Self-citationResistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Alfarouk, K. O., Stock, C.-M., Taylor, S., Walsh, M., Muddathir, A. K., Verduzco, D., Bashir, A. H. H., Mohammed, O. Y., Elhassan, G. O., Harguindey, S., et al. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0221-1 · Cited by 665
Chemical Sensors Based on Metal–Organic Frameworks
Yi, F., Chen, D., Wu, M., Han, L., & Jiang, H. (2016) · ChemPlusChem · doi:10.1002/cplu.201600137 · Cited by 660
Lykourinou, V., Chen, Y., Wang, X.-S., Meng, L., Hoang, T., Ming, L.-J., Musselman, R. L., & Ma, S. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2038003 · Cited by 658
Nanostructured metal–organic frameworks and their bio-related applications
Giménez-Marqués, M., Hidalgo, T., Serre, C., & Horcajada, P. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.08.008 · Cited by 574
Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011379108 · Cited by 513
Paclitaxel: a review of adverse toxicities and novel delivery strategies
Marupudi, N. I., Han, J. E., Li, K. W., Renard, V. M., Tyler, B. M., & Brem, H. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.5.609 · Cited by 510
Enzyme-Catalyzed Activation of Anticancer Prodrugs
Rooseboom, M., Commandeur, J. N. M., & Vermeulen, N. P. E. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.1.3 · Cited by 497
Metal–Organic Frameworks as Sensory Materials and Imaging Agents
Liu, D., Lu, K., Poon, C., & Lin, W. (2014) · Inorganic Chemistry · doi:10.1021/ic402194c · Cited by 386
Pol, A., Luetterforst, R., Lindsay, M., Heino, S., Ikonen, E., & Parton, R. G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.5.1057 · Cited by 326
A Review of Acetaminophen Poisoning
Hodgman, M. J., & Garrard, A. R. (2012) · Critical Care Clinics · doi:10.1016/j.ccc.2012.07.006 · Cited by 314
Prodrug strategies in cancer therapy
Denny, W. A. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01253-3 · Cited by 290
Coupling two enzymes into a tandem nanoreactor utilizing a hierarchically structured MOF
Lian, X., Chen, Y.-P., Liu, T.-F., & Zhou, H.-C. (2016) · Chemical Science · doi:10.1039/c6sc01438k · Cited by 277
Self-citationStimuli-responsive metal–organic frameworks gated by pillar[5]arene supramolecular switches
Tan, L.-L., Li, H., Qiu, Y.-C., Chen, D.-X., Wang, X., Pan, R.-Y., Wang, Y., Zhang, S. X.-A., Wang, B., & Yang, Y.-W. (2015) · Chemical Science · doi:10.1039/c4sc03749a · Cited by 268
Quantitative real-time imaging of glutathione
Jiang, X., Chen, J., Bajić, A., Zhang, C., Song, X., Carroll, S. L., Cai, Z.-L., Tang, M., Xue, M., Cheng, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms16087 · Cited by 268
Mechanized azobenzene-functionalized zirconium metal-organic framework for on-command cargo release
Meng, X., Gui, B., Yuan, D., Zeller, M., & Wang, C. (2016) · Science Advances · doi:10.1126/sciadv.1600480 · Cited by 251
Protease-Activated Drug Development
Choi, K. Y., Swierczewska, M., Lee, S., & Chen, X. (2012) · Theranostics · doi:10.7150/thno.4068 · Cited by 245
New regulators of melanin biosynthesis and the autodestruction of melanoma cells
Pawelek, J., Körner, A., Bergstrom, A., & Bologna, J. (1980) · Nature · doi:10.1038/286617a0 · Cited by 242
He, H., Han, H., Shi, H., Tian, Y., Sun, F., Song, Y., Li, Q., & Zhu, G. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b05538 · Cited by 228
Cytotoxic chemotherapy: clinical aspects
Corrie, P. G. (2008) · Medicine · doi:10.1016/j.mpmed.2007.10.012 · Cited by 227
Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review
Liu, F.-S. (2009) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60296-5 · Cited by 220
Zn2+‐Triggered Drug Release from Biocompatible Zirconium MOFs Equipped with Supramolecular Gates
Tan, L., Li, H., Zhou, Y., Zhang, Y., Feng, X., Wang, B., & Yang, Y. (2015) · Small · doi:10.1002/smll.201500155 · Cited by 216
Cao, S.-L., Yue, D.-M., Li, X.-H., Smith, T. J., Li, N., Zong, M.-H., Wu, H., Ma, Y.-Z., & Lou, W.-Y. (2016) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.6b00777 · Cited by 213
Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers
Hidalgo, T., Giménez-Marqués, M., Bellido, E., Avila, J., Asensio, M. C., Salles, F., Lozano, M. V., Guillevic, M., Simón-Vázquez, R., González-Fernández, A., et al. (2017) · Scientific Reports · doi:10.1038/srep43099 · Cited by 173
Lian, X., Erazo-Oliveras, A., Pellois, J.-P., & Zhou, H.-C. (2017) · Nature Communications · doi:10.1038/s41467-017-02103-0 · Cited by 172
Self-citationChen, Y., Lykourinou, V., Hoang, T., Ming, L.-J., & Ma, S. (2012) · Inorganic Chemistry · doi:10.1021/ic301280n · Cited by 169
A Smart Metal–Organic Framework Nanomaterial for Lung Targeting
Simón‐Yarza, T., Giménez‐Marqués, M., Mrimi, R., Mielcarek, A., Gref, R., Horcajada, P., Serre, C., & Couvreur, P. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707346 · Cited by 149
Prodrug Applications for Targeted Cancer Therapy
Giang, I., Boland, E. L., & Poon, G. M. K. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9638-z · Cited by 113
Harris, T. O., Shelver, D. W., Bohnsack, J. F., & Rubens, C. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316270 · Cited by 108
A Smart Metal–Organic Framework Nanomaterial for Lung Targeting
Simón‐Yarza, T., Giménez‐Marqués, M., Mrimi, R., Mielcarek, A., Gref, R., Horcajada, P., Serre, C., & Couvreur, P. (2017) · Angewandte Chemie · doi:10.1002/ange.201707346 · Cited by 101
Nanometric MIL-125-NH2 Metal–Organic Framework as a Potential Nerve Agent Antidote Carrier
Vilela, S. M. F., Salcedo‐Abraira, P., Colinet, I., Salles, F., de Koning, M. C., Joosen, M. J. A., Serre, C., & Horcajada, P. (2017) · Nanomaterials · doi:10.3390/nano7100321 · Cited by 97
Antibody directed enzyme prodrug therapy (ADEPT)
Bagshawe, K. D., Sharma, S. K., Springer, C. J., & Rogers, G. T. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058725 · Cited by 96
Milosavljevic, N., Duranton, C., Djerbi, N., Puech, P., Gounon, P., Lagadic‐Gossmann, D., Dimanche‐Boitrel, M., Rauch, C., Tauc, M., Counillon, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1253 · Cited by 86
Antibody-directed enzyme prodrug therapy (ADEPT) for cancer
Bagshawe, K. D., Sharma, S. K., & Beǵent, R. H. J. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.11.1777 · Cited by 81
Hua, W., Christianson, T. A., Rougeot, C., Rochefort, H., & Clinton, G. M. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00187-5 · Cited by 79
Metal–organic frameworks as potential multi-carriers of drugs
Rojas, S., Wheatley, P. S., Procopio, E. Q., Gil, B., Marszałek, B., Morris, R. E., & Barea, E. (2013) · CrystEngComm · doi:10.1039/c3ce41289j · Cited by 75
Nolan, D. P., Rolin, S., Rodriguez, J. R., Abbeele, J. V. D., & Pays, É. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.00935.x · Cited by 69
Lee, H. H., Bellat, V., & Law, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171044 · Cited by 69
Raymond, K. S., Grafton, A. K., & Wheeler, R. A. (1997) · The Journal of Physical Chemistry B · doi:10.1021/jp961852h · Cited by 67
Yan, X., Li, M., Yuan, Y., Mao, N., & Pan, L. (2007) · Oncology Reports · doi:10.3892/or.17.5.1163 · Cited by 55
A new application for liposomes in cancer therapy
Vingerhoeds, M. H., Haisma, H. J., van Muijen, M., et al. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80861-n · Cited by 51
Guo, C., Wang, W., Feng, W., & Li, P. (2017) · RSC Advances · doi:10.1039/c7ra00783c · Cited by 18
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Niu, B., Liao, K., Zhou, Y., Wen, T., Quan, G., Pan, X., & Wu, C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121110 · Cited by 1,168
Metal–Organic Frameworks for Biomedical Applications
Yang, J., & Yang, Y. (2020) · Small · doi:10.1002/smll.201906846 · Cited by 998
Metal–Organic Framework-Based Enzyme Biocomposites
Liang, W., Wied, P., Carraro, F., Sumby, C. J., Nidetzky, B., Tsung, C.-K., Falcaro, P., & Doonan, C. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01029 · Cited by 784
Metal–Organic Framework Nanocarriers for Drug Delivery in Biomedical Applications
Sun, Y., Zheng, L., Yang, Y., Qian, X., Fu, T., Li, X., Yang, Z., Yan, H., Cui, C., & Tan, W. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00423-3 · Cited by 723
Metadata
- Authors
- Lian, X., Huang, Y., Zhu, Y., Fang, Y., Zhao, R., Joseph, E., Li, J., Pellois, J., & Zhou, H.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2018-04-14
- Volume
- 57
- Issue
- 20
- Pages
- 5725-5730
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2791332947
- Cited by
- 283
- References
- 53
- FWCI
- 14.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.